Citadel Advisors’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Citadel Advisors’s Portfolio CDIOW Stock Details CDIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,631	Closed	-$454	–	14578
2024 Q3	$454	Buy	+11,631	New	+$438	﹤0.01%	14017

Other funds holding CDIOW

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Citadel Advisors's CDIOW Position: Q4 2024 in Review

Citadel Advisors sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q4 2024, closing a stake of 11,631 shares — an estimated $454 sold.

Citadel Advisors first reported a position in CDIOW in Q3 2024 and held it in 1 quarter. The position peaked at $454 in Q3 2024. 6 funds tracked by Wall St. Rank hold CDIOW as of Q4 2024.

Citadel Advisors reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q4 2024 after selling out during the quarter.
Citadel Advisors sold 11,631 Cardio Diagnostics Holdings Inc Warrant shares in Q4 2024, an estimated $454.
Citadel Advisors first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q3 2024 and held it in 1 quarter.
Citadel Advisors's Cardio Diagnostics Holdings Inc Warrant position peaked at $454 in Q3 2024.
6 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.